The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of Axl, a therapeutic target in AML, to mediate stroma-induced chemoresistance.
Isabel Ben Batalla
No relevant relationships to disclose
Alexander Schultze
No relevant relationships to disclose
Mark Wroblewski
No relevant relationships to disclose
Robert Erdmann
No relevant relationships to disclose
Michael Heuser
No relevant relationships to disclose
Kristoffer Riecken
No relevant relationships to disclose
Mascha Binder
No relevant relationships to disclose
Miguel Cubas-Cordova
No relevant relationships to disclose
Janning Melanie
No relevant relationships to disclose
Jasmin Wellbrock
No relevant relationships to disclose
Boris Fehse
No relevant relationships to disclose
Christian Hagel
No relevant relationships to disclose
Jürgen Krauter
No relevant relationships to disclose
James B. Lorens
No relevant relationships to disclose
Arnold Ganser
No relevant relationships to disclose
Walter M. Fiedler
No relevant relationships to disclose
Peter Carmeliet
No relevant relationships to disclose
Klaus Pantel
No relevant relationships to disclose
Carsten Bokemeyer
No relevant relationships to disclose
Sonja Loges
No relevant relationships to disclose